Article Per Year (5 Year)
p-Index From 2020 - 2025
0.61
P-Index
This Author published in this journals
All Journal JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Majalah Farmaseutik Media Ilmu Kesehatan JSFK (Jurnal Sains Farmasi & Klinis)
Tri Murti Andayani
Fakultas Farmasi Universitas Gadjah Mada
Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 5 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 5 Documents
Search

 1 
EVALUASI KINERJA MENGGUNAKAN METODE BALANCED SCORECARD PADA APOTEK XX YOGYAKARTA TAHUN 2019 Ahmad Suriyadi Muslim; Titik Sunarni; Tri Murti Andayani
MEDIA ILMU KESEHATAN Vol 9 No 2 (2020): Media Ilmu Kesehatan
Publisher : Universitas Jenderal Achmad Yani Yogyakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30989/mik.v9i2.349

Abstract

Background: The growth rate of pharmacy in the city of Yogyakarta is very rapid so that it can cause competition between pharmacy. Objective: Pharmacy service performance is very important to be reviewed because it can be used as a parameter to determine management strategies. One method that is recommended in assessing pharmacy performance is the balanced scorecard method. Methods: This research is non-experimental explorative descriptive design with the aim to find out the performance of the apotek XX Yogyakarta based on four perspectives of the balanced scorecard method, financial side, customer, internal business processes, learning and growth of pharmacy and provide recommendations for improvement based on the results of the performance evaluation. Data collection was conducted retrospectively and prospectively in the form of qualitative and quantitative data. Results: The results of the performance apotek XX Yogyakarta using the balanced scorecard method research from a financial perspective shows the value of ITOR has decreased every year, Internal business process perspective is still found the existence of DRP and pharmacies have not met 100% of drug needs and in the perspective of learning and employee productivity growth is valued less. Conclusion: However, over all the results are good because it meets the standard values.
Risiko Kejadian Perdarahan Pasca Rawat Inap pada Penggunaan Bersamaan Warfarin dan Antibiotik Nazulanita Rahma; Tri Murti Andayani; Arief Nurrochmad
Jurnal Sains Farmasi & Klinis Vol 8, No 2 (2021): J Sains Farm Klin 8(2), Agustus 2021
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (535.191 KB) | DOI: 10.25077/jsfk.8.2.164-173.2021

Abstract

Penggunaan warfarin dan antibiotik bersamaan diketahui dapat meningkatkan risiko perdarahan. Kejadian perdarahan mayor terkait warfarin dapat berupa perdarahan fatal hingga menyebabkan kematian. Penelitian ini bertujuan untuk menganalisis interaksi warfarin dan antibiotik dan efeknya terhadap kejadian perdarahan pada pemeriksaan pertama pasca rawat inap di RSUD Wates. Desain studi berupa kohort retrospektif pada 67 kasus penggunaan warfarin dengan/tanpa antibiotik oleh pasien rawat inap. Data berupa diagnosis, terapi, pemeriksaan pendukung, dan kejadian perdarahan saat rawat inap hingga pemeriksaan pertama diambil dari rekam medik pasien tertanggal Januari 2018 hingga September 2020. Analisis data dilakukan secara statistika menggunakan ­uji Chi-square atau uji Fisher exact test dan uji independent t-test atau uji Mann Whitney U test. Terdapat perbedaan bermakna pada kejadian perdarahan dalam waktu 7 hari pasca rawat inap antara kelompok antibiotik dan kontrol (16%; 0%; p = 0.017). Antibiotik yang digunakan oleh pasien dengan kejadian perdarahan yaitu golongan sefalosporin, kuinolon, azitromisin, dan ampisilin-sulbaktam. Kejadian perdarahan yang terjadi meliputi hematemesis melena (25%), hematuria (50%), tidak diketahui (25%). Studi ini menyimpulkan bahwa penggunaan bersamaan warfarin dan antibiotik saat rawat inap dapat berpengaruh terhadap kejadian perdarahan dalam waktu 7 hari setelah pasien dipulangkan.Penggunaan warfarin dan antibiotik bersamaan diketahui dapat meningkatkan risiko perdarahan. Kejadian perdarahan mayor terkait warfarin dapat berupa perdarahan fatal hingga menyebabkan kematian. Penelitian ini bertujuan untuk menganalisis interaksi warfarin dan antibiotik dan efeknya terhadap kejadian perdarahan pada pemeriksaan pertama pasca rawat inap di RSUD Wates. Desain studi berupa kohort retrospektif [A1] [A2] pada 67 kasus penggunaan warfarin dengan/tanpa antibiotik oleh pasien rawat inap. Data berupa diagnosis, terapi, pemeriksaan pendukung, dan kejadian perdarahan saat rawat inap hingga pemeriksaan pertama diambil dari rekam medik pasien tertanggal Januari 2018 hingga September 2020. Analisis data dilakukan secara statistika menggunakan ­uji Chi-square atau uji Fisher exact test dan uji independent t-test atau uji Mann Whitney U test. Terdapat perbedaan bermakna pada kejadian perdarahan dalam waktu tujuh hari pasca rawat inap antara kelompok antibiotik dan kontrol (16%; 0%; p = 0.017). [A3] [A4] Antibiotik yang digunakan oleh pasien dengan kejadian perdarahan yaitu azitromisin, ampisilin-sulbaktam, golongan sefalosporin, dan golongan kuinolon.[A5] [A6]  Kejadian perdarahan yang terjadi meliputi hematemesis melena (25%), hematuria (50%), tidak diketahui (25%). Studi ini menyimpulkan bahwa penggunaan bersamaan warfarin dan antibiotik saat rawat inap dapat berpengaruh terhadap kejadian perdarahan dalam waktu tujuh hari setelah pasien dipulangkan [A1]Penulis disarankan mempelajari artikel https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398292/ untuk lebih memahami penulisan artikel dengan desain kohort. [A2]Baik, terimakasih [A3]Tampilan hasil uji dalam studi kohort (adjusted hazard ratio [AHR] = ?; 95% CI, ?; p-value = ) [A4]Tidak dilakukan analisis survival, sementara kejadian perdarahan pada control group adalah 0 sehingga RR adalah tidak terbatas [A5]Ini bukan golongan obat; untuk menghindari multitafsir..kedua obat ini ditulis di awal, sementara yang golongan obat di bagian setelahnya [A6]Sudah kami ubah redaksionalnya
THERAPY COST ANALYSIS AND EFFECTIVENESS OF TREATMENT OF OUTPATIENT WITH TYPE 2 DIABETES MELLITUS AT RSUD SLEMAN YOGYAKARTA Pratiwi Dinaryanti; Achmad Fudholi; Tri Murti Andayani
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 2, No 1
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.54

Abstract

Diabetes is a chronic disease that can significantly increase a person›s risk of having complications. These complications not only cause the inability of the body that will affect the quality of life, but also need big cost. This research was conducted to analyze the costs and effectiveness of therapies of outpatient with type 2 diabetes mellitus. A crosssectional observational method was performed on 100 patient who were admitted to the Department of Endocrinology of the Sleman Hospital between December 2010 to January 2011. Data were taken in 2 ways: concurrent and retrospective, with accidental sampling technique. The subject of this research were outpatient with type 2 diabetes mellitus at RSUD Sleman Yogyakarta, who have used the antidiabetic therapy for at least three months of therapy before the quality of life measurement. The costs that are measured are direct medical costs, antidiabetic costs, complication costs, laboratory examination costs, and administration costs. The effectiveness of treatment parameters was measured based on the percentage of patients with fasting blood glucose level (GDP) and post-prandial blood glucose (GDPP) which reached the target in the third month of therapy, and achievement of the quality of life research subjects. The Lowest total cost of therapy was the use of glibenclamide, it was 49.730,00, the highest total cost of therapy was the use of insulin, it was Rp. 411.045,50. T test results with 95% confidence level indicates that the patient characteristics and medication adherence complications affect the patients quality of life, whereas non-pharmacological therapy (exercise and diet) did not significantly influence the patients quality of life. The results of measurements of quality of life showed metformin achieved the best quality of life than the other antidiabetic, i.e. 72.53. Based on the effectiveness of the three parameters (measurement of quality of life and levels of GDP and GDPP) note that metformin therapy tend to be more effective compared with other antidiabetic therapies.Key words: Diabetes mellitus type 2, cost analysis, effectiveness, antidiabetic, RSUD Sleman Yogyakarta.
THE EVALUATION OF POLICY EFFECT ON GENERIK MEDICINE PRICES 2010 TOWARD SELLING PRICE, THEIR AVAILABILITY AND AFFORDABILITY IN PRIVATE PHARMACIES IN KABUPATEN JEMBER Ika Norcahyanti; Djoko Wahyono; Tri Murti Andayani
JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice) Vol 1, No 3
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jmpf.14

Abstract

One of government’s efforts to guarantee people access on essential medicine is by applying a policy concerning with generic medicine prices. The purpose of the research was to find out the variation and the ratio of generik and branded medicine selling prices in comparison with Harga Jual Apotek (HJA) – Pharmacy Selling Price – based on the regulation of Health Mi n i s t r y and International Reference Prices (IRPs) 2010 and their availability and affordability in some private pharmacios in Jember. The research design was a descriptive non experimental. The data collected retrospectively toward generik and branded medicines mostly prescribe during April-August 2010 include their prices and affordability. Research result showed that the ratio of generik medicine selling price toward HJA was 0.14-9.09 times and 0.26-114.06 times. On the other hand, the ratio of generic and branded medicine selling price toward IRPs 2010 was 0.03-16.67 times and 0.09-501.88 times. In 50 kinds of mostly prescribed medicines, 35 of them were generik medicines with affordibility range 11.4%-93.2%. In the matter of affordability, it needs 1 working day to do a therapy using generik medicines for diabetes mellitus, hypertension, hypercholesterolemia, rheumatoid arthritis, and infection cases. In contrast, it requires 1-35 working days to do those therapies using branded medicines with Regional Minimum Salary of Rp.33.200.00 for each working day. Keywords : generic medicine price policy, pharmachy selling price, medicine avalaibility, medicine avordbility,Jember.
Evaluasi Management Support pada Pengelolaan Obat di RSUD Kabupaten Ngawi Fita Dewi Yuniarti; Satibi Satibi; Tri Murti Andayani
Majalah Farmaseutik Vol 17, No 1 (2021)
Publisher : Faculty of Pharmacy, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/farmaseutik.v17i1.52157

Abstract

Pengelolaan obat yang efektif dan efisien di instalasi farmasi rumah sakit meliputi tahap seleksi, pengadaan, distribusi dan penggunaan yang didukung oleh manajemen pendukung (management support) yang terdiri dari perencanaan administrasi, organisasi, sumber daya manusia, sistem informasi.Tujuan penelitian ini untuk mengetahui gambaran management support terhadap pengelolaan obat di Instalasi Farmasi RSUD Kabupaten Ngawi. Penelitian ini bersifat deskriptif menggunakan metode wawancara dan telaah dokumen. Data kuantitatif diambil secara retrospektif (tahun 2018); dan data kualitatif diperoleh dari wawancara dengan informan yang dipilih secara purposive sampling. Data hasil penelusuran dokumen dan wawancara diklasifikasikan menjadi 2 kelompok yaitu data kualitatif dan data kuantitatif. Data kualitatif berupa hasil wawancara disajikan dalam bentuk tekstual berupa narasi. Data kuantitatif dibandingkan dengan standar, kemudian disajikan dalam bentuk tabel.Dari hasil penelitian ini menunjukkan perencanaan dan administrasi pada persentase kesesuaian jumlah permintaan dan perencanaan 103,18%; persentase stok obat mati 0,4%; persentase obat ED 0,36%. dari manajemen organisasi, sudah terdapat struktur organisasi yang jelas sesuai dengan tugas, pokok dan fungsinya. Dari manajemen sumber daya manusia, memerlukan penambahan SDM apoteker. Dari manajemen sistem informasi: SIM yang ada hanya lokal untuk instalasi farmasi. Dari hasil penelitian ini menunjukkan bahwa pengelolaan obat di IFRS RSUD Kabupaten Ngawi  belum efisien, karena belum didukung sepenuhnya oleh management support yang baik.
Co-Authors Achmad Fudholi Ahmad Suriyadi Muslim Arief Nurrochmad Djoko Wahyono Fita Dewi Yuniarti Ika Norcahyanti Nazulanita Rahma Pratiwi Dinaryanti Satibi Satibi Titik Sunarni